Use of topical corticosteroids in children with eczema does not have negative side effects
April 21, 2011 in MedicationsA new study published in the journal Pediatric Dermatology reveals that routine, long-term use of topical corticosteroids (TCS) for treating children with eczema does not cause any significant, negative side effects.
Parental phobia of TCS is widespread and leads to poorly managed eczema in children. The commonest fear is that TCS use will "thin the skin." Parents fears are also shared by many health care providers, including pharmacists.
Led by Gayle Fischer, MBBS, FACD, of The University of Sydney, researchers studied 92 children, 70 of which were part of the study/dermatitis group while the other 22 were categorized in a control group. Researchers convinced the parents of these 70 children to use enough TCS to control their children's eczema very well so that they were virtually free of eczema consistently. The 22 children in the control group were not using TCS.
Researchers then evaluated the children by examining them for any signs of skin thinning and by also examining their treated and untreated skin by dermoscopy, a technique which utilizes a mini-microscope to search for even the most subtle signs of TCS side effects.
They found that the children using TCS had no evidence of skin thinning even though they were using enough TCS to produce complete control of their eczema. These children were no different to the children who were not using TCS at all.
"Our results show that normal routine use of TCS does not cause skin thinning, and parents should be reassured. We hope that our work will give them the confidence to use TCS safely and effectively" Fischer notes.
Provided by
Wiley
-
Dog ownership is associated with reduced eczema in children with dog allergies
Sep 30, 2010 |
not rated yet |
0
-
India's TCS quarterly profit jumps 21 percent
Jul 15, 2010 |
not rated yet |
0
-
India software giant TCS profits up 30%
Jan 17, 2011 |
not rated yet |
0
-
India's TCS announces 29 pct quarterly profit jump
Oct 16, 2009 |
not rated yet |
0
-
Probiotic bacteria don't make eczema better -- and may have side effects
Oct 08, 2008 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
5 hours ago |
not rated yet |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
Math and dyslexia?
16 hours ago
-
portable metabolism meter?
May 21, 2012
-
Rare medical conditions on 20/20 tonight
May 18, 2012
-
"Good" Cholesterol in Doubt
May 17, 2012
-
A couple of questions about schizophrenia
May 17, 2012
-
Paralyzed woman uses thoughts to move robotic arm
May 17, 2012
- More from Physics Forums - Medical Sciences
More news stories
Antidepressant use associated with increased mortality among critically ill patients?
Researchers at Beth Israel Deaconess Medical Center, in Boston, and the Massachusetts Institute of Technology in Cambridge, have found that critically ill patients were more likely to die if they were taking the most commonly ...
Medications
5 hours ago |
not rated yet |
0
Antibiotics boost risk of infection with antifungal-resistant candida
Previous exposure to certain antibiotics could boost the risk of infection with drug-resistant strains of a severe fungal infection. Researchers report their findings in the May 2012 issue of the journal Antimicrobial Ag ...
Medications
6 hours ago |
not rated yet |
0
New blood thinner may lower chances of clots in high-risk heart patients: FDA
(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.
Medications
17 hours ago |
not rated yet |
0
Generic versions of plavix approved
(HealthDay) -- The first generic versions of Plavix (clopidogrel bisulfate) have been approved by the U.S. Food and Drug Administration.
Medications
May 18, 2012 |
not rated yet |
0
'Last resort' antibiotics increasingly used to fight multidrug-resistant bugs
Multidrug-resistant pathogens are becoming more frequent, and the few "last resort" treatments available for infections with these bacteria have also shown an increase in use in recent years, according to a study published ...
Medications
May 16, 2012 |
not rated yet |
0
Body building, diet supplements linked to liver damage: study
(HealthDay) -- Body-building and weight-loss products are the types of dietary supplements most likely to cause liver injury, according to a small new study.
Limits to growth: Scientists identify key metastasis-enabling enzyme
(Medical Xpress) -- On the complex road to eradicating cancer, controlling or preventing metastatic growth initiated by primary tumors is high on the to-do list. A key area of such research is the development ...
Do bald men face higher risk of prostate cancer?
(HealthDay) -- Got hair? If you don't, you might have a higher risk of prostate cancer, a preliminary study suggests.
Asthma medication linked with arrhythmias in children, young adults
Use of inhaled anticholinergics (IACs) has been associated with an increased risk of potentially dangerous heart arrhythmias among young asthma patients, according to a study conducted by researchers at the University of ...
U.S. liver transplants declining
(HealthDay) -- The number of liver transplants in the United States has decreased since 2006, a new study finds.
Neuron-nourishing cells appear to retaliate in Alzheimer's
When brain cells start oozing too much of the amyloid protein that is the hallmark of Alzheimer's disease, the astrocytes that normally nourish and protect them deliver a suicide package instead, researchers ...